April 1 (Reuters) - Theratechnologies Inc TH.TO :
* STUDY CONFIRMS TESAMORELIN SIGNIFICANTLY REDUCES LIVER FAT IN HIV PATIENTS WITH NAFLD
* THERATECHNOLOGIES - TOP-LINE RESULTS CONCLUDE THAT TESAMORELIN SIGNIFICANTLY REDUCES LIVER FAT IN HIV PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE
* THERATECHNOLOGIES INC - STUDY ACHIEVED ITS PRE-SPECIFIED PRIMARY ENDPOINT
* THERATECHNOLOGIES INC - SECONDARY ENDPOINTS SUGGEST POTENTIAL BENEFITS FOR FIBROSIS PREVENTION AS PRELIMINARY RESULTS ARE SHOWING LESS PROGRESSION